A control and case study of multiple sclerosis in the Alicante and Villajoyosa areas;Estudio de casos y controles sobre la esclerosis múltiple en las áreas de Alicante y Villajoyosa

Revista de Neurologia

Volumn 34, Issue 11, 2002, Pages 1013-1016

  Frutos Alegría, María Teresa ^a   Beltran Blasco I ^a   Quilez Iborra C ^a   Molto Jorda J M ^a   Diaz Marin C ^a   Matias Guiu J ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

Alicante; Control and case studies; Dogs; Epidemiology; Measles; Multiple sclerosis

Indexed keywords

ADULT; AGE; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DOG; EDUCATION; EMERGENCY HEALTH SERVICE; ENVIRONMENTAL FACTOR; FAMILY; FAMILY HISTORY; FEMALE; GENDER; GEOGRAPHY; HEADACHE; HOME; HOSPITAL; HUMAN; MALE; MEASLES; MULTIPLE SCLEROSIS; SMOKING; SOCIAL CLASS; SPAIN; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0036627016     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3411.2001503     Document Type: Article

References (23)

1. Beltrán I, Ferri L, Ribera C, Moltó JM, Martín R, Díaz-Marín C, et al. Estudio de casos y controles sobre la esclerosis múltiple en Alcoy. Rev Neurol 1997; 25: 1399-401.
2. Beltrán I, Moltó JM, Díaz-Marín C, Martín R, Matías-Guiu J. Estudio epidemiológico analítico sobre la esclerosis múltiple en Alcoy. Rev Neurol 1998; 26: 67-9.
3. Rose AS, Ellison GW, Myers LW, Tourtelotte WW. Criteria for the clinical diagnosis of multiple sclerosis. Neurology 1976; 26: 20-2.
4. Koch-Henriksen N. An epidemiological study of multiple sclerosis. Familial aggregation, social determinants and exogenic factors. Acta Neurol Scand 1989; 80 (Suppl 124): 1-213.
5. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-52.
6. Mallada-Frechin J, Matías-Guiu J, Martín R, López-Arlandis JM, Camacho-Cuartero JM, Beltrán I, et al. Incidencia de la esclerosis múltiple en el área sanitaria de Alcoy. Estudio de 12 años (1986-1997). Rev Neurol 2000; 30: 1128-31.
7. Atkins GJ, McQuaid S, Morris-Downes MM, Galbraith SE, Amor S, Cosby SL, et al. Transient virus infection and multiple sclerosis. Rev Med Virol 2000; 10: 291-303.
8. Smith-Jensen T, Burgoon MP, Anthony J, Kraus H, Gilden DH, Owens GP. Comparison of immunoglobulin G heavy-chain sequences in MS and SSPE brains reveals an antigen-driven response. Neurology 200; 54: 1227-32.
9. Enbom M. Human herpesvirus 6 in the pathogenesis of multiple sclerosis. APMIS 2001; 109: 401-11.
10. Cook SD, Dowling PC. A possible association between house pets and multiple sclerosis. Lancet 1977; 1: 980-2.
11. Kurtzke JF, Hyllested K, Arbuckle JD, Baerentsen DJ, Jersild C, Madden DL, et al. Multiple sclerosis in the Faroe Islands. IV. The lack of a relationship between canine distemper and the epidemics of MS. Acta Neurol Scand 1988; 78: 485-500.
12. Anderson LJ, Kibler RF, Kaslow RA, Austin J, Holman RC. Multiple sclerosis unrelated to dog exposure. Neurology 1984; 34: 1149-54.
13. Rohowsky-Kochan C, Dowling PC, Cook SD. Canine distemper virus-specific antibodies in multiple sclerosis. Neurology 1995; 4: 1554-60.
14. Hodge MJ, Wolfson C. Canine distemper virus and multiple sclerosis. Neurology 1997; 49 (Suppl 2): S62-9.
15. Hernan MA, Zhang SM, Lipworth L, Olek MJ, Ascherio A. Multiple sclerosis and age at infection with common viruses. Epidemiology 2001; 12: 301-6.
16. 2-adrenergic receptors on astrocytes in canine distemper encephalitis: possible implications for the pathogenesis of multiple sclerosis. Neuroreport 2001; 12: 191-4.
17. Casetta I, Granieri E. Clinical infections and multiple sclerosis: contribution from analytical epidemiology. J Neurovirol 2000; 6 (Suppl 2): S 147-51.
18. Souberbielle BE, Martin-Mondiere C, O'Brien ME, Carydakis C, Cesaro P, Degos JD. A case-control epidemiological study of MS in the Paris area with particular reference to past disease history and profession. Acta Neurol Scand 1990; 82: 303-10.
19. Haghighi S, Andersen O, Rosengren L, Bergstrom T, Wahlstrom J, Nilsson S. Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls. J Neurol 2000; 247: 616-22.
20. Derfuss T, Gurkov R, Then-Bergh F, Goebels N, Hartmann M, Barz C, et al. Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response. Brain 2001; 124: 1325-35.
21. Casetta I, Granieri E, Malagu S, Tola MR, Paolino E, Caniatti LM, et al. Environmental risk factors and multiple sclerosis: a community-based, case-control study in the province of Ferrara, Italy. Neuroepidemiology 1994; 13: 120-8.
22. Hernan MA, Oleky MJ, Ascherio A. Cigarette smoking and incidence of multiple sclerosis. Am J Epidemiol 2001; 154: 69-74.
23. Rosati G, Aiello I, Pirastru MI, Mannu L, Demontis G, Becciu S, et al. Sardinia, a high risk area for multiple sclerosis: a prevalence and incidence study in the district of Alghero. Neurology 1987; 21: 190-4.